glycyrrhetinic acid

Preferred Label : glycyrrhetinic acid;

MeSH definition : An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation.;

MeSH synonym : acid, uralenic; acid, glycyrrhetic; glycyram; glyciram; jintan; enoxolone; acid, glycyrrhetinic; glycyrrhetic acid; rhetinic acid; acid, rhetinic; uralenic acid;

CISMeF synonym : dexo brand of glycyrrhetinic acid; plantes et médecines brand of glycyrrhetinic acid;

MeSH hyponym : arthrodont; po 12; 12, Po;

MeSH CAS label : Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-;

MeSH Related Number : 471-53-4 (Glycyrrhetinic acid);

Registry Number MeSH : 471-53-4;

Wikipedia link : https://en.wikipedia.org/wiki/Glycyrrhetinic acid;

Codes EINECS : 207-444-6;

Is substance : O;

UNII : P540XA09DR;

InChIKey : MPDGHEJMBKOTSU-YKLVYJNSSA-N;

Details

Origin ID

D006034;

UMLS CUI

C0017986;

ATC code(s)
- enoxolone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Enoxolone (substance) [SNOMED CT concept]
- enoxolone [Substance BNPC]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
Record concept(s)
- arthrodont [MeSH concept]
- glycyrrhetinic acid [MeSH concept]
- po 12 [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11-deoxy glycyrrhetinic acid [MeSH Supplementary Concept]
- 11-deoxy-18alpha-glycyrrhetinic acid [MeSH Supplementary Concept]
- 11-deoxy-18alpha-glycyrrhetinic acid-30-ethyl ester [MeSH Supplementary Concept]
- 18-dehydroglycyrrhetic acid [MeSH Supplementary Concept]
- 18-olean-9(11),12-diene-3,30-diol dihemiphthalate [MeSH Supplementary Concept]
- 18alpha-glycyrrhetinic acid [MeSH Supplementary Concept]
- 18beta-glycyrrhetinic acid-3-O-beta-D-glucuronide [MeSH Supplementary Concept]
- 2,3,4,5,5a,6,7,7a,7b,8,9,9a,10,11,12,13,13a,15,15a,15b-eicosahydro-5,5,7a,7b,9a,12,15b-heptamethyl-3,15-dioxo-N-hydroxy-N-methyl-1H-chryseno(2,1-c)azepine-12-carboxylic acid amide [MeSH Supplementary Concept]
- 27-hydroxyglycyrrhentic acid [MeSH Supplementary Concept]
- 3-alpha-hydroxyglycyrrhetic acid [MeSH Supplementary Concept]
- 3-oxoglycyrrhetinic acid [MeSH Supplementary Concept]
- 6,7-dihydroxyglycyrrhentic acid [MeSH Supplementary Concept]
- LPD gingival message agent [MeSH Supplementary Concept]
- MAS063DP [MeSH Supplementary Concept]
- N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide [MeSH Supplementary Concept]
- acetylglycyrrhetinic acid [MeSH Supplementary Concept]
- ammonium glycyrrhetinate [MeSH Supplementary Concept]
- apioglycyrrhizin [MeSH Supplementary Concept]
- araboglycyrrhizin [MeSH Supplementary Concept]
- ascorbic acid 2-(11-oxoolean-12-en-29-oic acid ethyl ester 3-yl-phosphate) [MeSH Supplementary Concept]
- benzocaine, chlorhexidine, enoxolone drug combination [MeSH Supplementary Concept]
- deoxoglycyrrhetol dihemiphthalate [MeSH Supplementary Concept]
- enoxolone, hyaluronic acid, levomenol, telmesteine, vitis vinifera drug combination [MeSH Supplementary Concept]
- ganluotong [MeSH Supplementary Concept]
- glycyrrhetic acid mono-glucuronide [MeSH Supplementary Concept]
- glycyrrhetinic acid 3-O-hemiphthalate [MeSH Supplementary Concept]
- glycyrrhetinyl-glycine conjugate [MeSH Supplementary Concept]
- glycyrrhetyl 3-monoglucuronide [MeSH Supplementary Concept]
- glycyrrhetyl 30-monoglucuronide [MeSH Supplementary Concept]
- glycyrrhizin sulfate [MeSH Supplementary Concept]
- glyderinine [MeSH Supplementary Concept]
- lauroylglycyrrhetinic acid [MeSH Supplementary Concept]
- licorice acid [MeSH Supplementary Concept]
- licorice extract - magnesium aluminometasilicate [MeSH Supplementary Concept]
- methyl 18-hydroxyglycyrrhetate [MeSH Supplementary Concept]
- methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate [MeSH Supplementary Concept]
- methyl 2-cyano-3,11-dioxooleana-1,12-dien-30-oate [MeSH Supplementary Concept]
- methyl 2-cyano-3,12-dioxooleana-1, 12-dien-30-oate [MeSH Supplementary Concept]
- olean-11,13(18)-diene-3,30-diol dihemiphthalate, disodium salt [MeSH Supplementary Concept]
- olean-9(11),12-diene-3,30-diol 3-O-hemisuccinate [MeSH Supplementary Concept]
- stearyl glycyrrhetinate [MeSH Supplementary Concept]
- stronger neominophagen C [MeSH Supplementary Concept]
- uralenolide [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing enoxolone (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Enoxolone [NCIt concept]
- Enoxolone (substance) [SNOMED CT concept]
- Product containing enoxolone (medicinal product) [SNOMED CT concept]
- enoxolone [ATC Code]
- enoxolone [Substance BNPC]
Validated automatic mappings to BTNT
- enoxolone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients